Neglected Tropical Diseases Drugs and Vaccine Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2018-2032)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2018-2023)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2032)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2018-2023)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2018-2023)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2022
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2018-2023)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2032)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2018-2023)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2018-2032)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023)
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Detail
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Detail
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Detail
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Detail
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Detail
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2018-2023)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2023-2032)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2018-2023)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2018-2023)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2023-2032)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2018-2023)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2023-2032)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 37. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 39. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2023-2032) & (US$ Million)
Table 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2032) & (US$ Million)
Table 45. Artecef BV Company Detail
Table 46. Artecef BV Business Overview
Table 47. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 48. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 49. Artecef BV Recent Development
Table 50. GlaxoSmithKline Company Detail
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 53. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 54. GlaxoSmithKline Recent Development
Table 55. AstraZeneca Company Detail
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 58. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 59. AstraZeneca Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 63. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Sanofi-Aventis Company Detail
Table 66. Sanofi-Aventis Business Overview
Table 67. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 69. Sanofi-Aventis Recent Development
Table 70. Ranbaxy Labs Company Detail
Table 71. Ranbaxy Labs Business Overview
Table 72. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 74. Ranbaxy Labs Recent Development
Table 75. Lupin Company Detail
Table 76. Lupin Business Overview
Table 77. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 79. Lupin Recent Development
Table 80. Macleods Pharmaceuticals Company Detail
Table 81. Macleods Pharmaceuticals Business Overview
Table 82. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 84. Macleods Pharmaceuticals Recent Development
Table 85. Cipla Company Detail
Table 86. Cipla Business Overview
Table 87. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 89. Cipla Recent Development
Table 90. Romark Laboratories Company Detail
Table 91. Romark Laboratories Business Overview
Table 92. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 94. Romark Laboratories Recent Development
Table 95. Toyama Chemica Company Detail
Table 96. Toyama Chemica Business Overview
Table 97. Toyama Chemica Neglected Tropical Diseases Drugs and VaccineProduct
Table 98. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023) & (US$ Million)
Table 99. Toyama Chemica Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2022 VS 2032
Figure 2. Malaria Features
Figure 3. Ebola Features
Figure 4. Dengue Features
Figure 5. Chagas Features
Figure 6. Leishmaniasis Features
Figure 7. Other Features
Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2022 & 2032
Figure 9. Drugs Case Studies
Figure 10. Vaccines Case Studies
Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2022 VS 2032
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2022
Figure 16. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2022
Figure 18. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 20. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 24. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2018-2032)
Figure 32. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 40. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2018-2032)
Figure 44. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 46. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 50. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 51. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 52. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 53. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 54. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 55. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 56. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Industry Market Size
